prednisone has been researched along with Neurocysticercosis in 14 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Neurocysticercosis: Infection of the brain, spinal cord, or perimeningeal structures with the larval forms of the genus TAENIA (primarily T. solium in humans). Lesions formed by the organism are referred to as cysticerci. The infection may be subacute or chronic, and the severity of symptoms depends on the severity of the host immune response and the location and number of lesions. SEIZURES represent the most common clinical manifestation although focal neurologic deficits may occur. (From Joynt, Clinical Neurology, 1998, Ch27, pp46-50)
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this trial, 178 patients with active or transitional neurocysticercosis cysts and new-onset symptoms were randomized to 8 days of treatment with albendazole (n=88) or placebo (n=90), both with prednisone, and followed for 24 months." | 9.20 | The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis. ( Andrews, H; Bagiella, E; Carpio, A; Hauser, WA; Kelvin, EA; Leslie, D; Romo, ML; Wyka, K, 2015) |
| "The aim of this trial was to evaluate the effects of albendazole (ALB) on cyst disappearance, reduction of the number of cysts and seizure recurrence." | 9.13 | Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. ( Andrews, H; Bagiella, E; Carpio, A; Hauser, WA; Kelvin, EA; Leon, P; Leslie, D, 2008) |
| "Neurocysticercosis is the most common parasitic infection of the central nervous system." | 5.33 | Resolution of arterial stenosis in a patient with periarterial neurocysticercosis treated with oral prednisone. ( Bouldin, A; Pinter, JD, 2006) |
| "In this trial, 178 patients with active or transitional neurocysticercosis cysts and new-onset symptoms were randomized to 8 days of treatment with albendazole (n=88) or placebo (n=90), both with prednisone, and followed for 24 months." | 5.20 | The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis. ( Andrews, H; Bagiella, E; Carpio, A; Hauser, WA; Kelvin, EA; Leslie, D; Romo, ML; Wyka, K, 2015) |
| "The aim of this trial was to evaluate the effects of albendazole (ALB) on cyst disappearance, reduction of the number of cysts and seizure recurrence." | 5.13 | Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. ( Andrews, H; Bagiella, E; Carpio, A; Hauser, WA; Kelvin, EA; Leon, P; Leslie, D, 2008) |
| "Neurocysticercosis is the most common parasitic infection of the brain." | 2.50 | Neurocysticercosis in Wisconsin: 3 cases and a review of the literature. ( Naddaf, E; Seeger, SK; Stafstrom, CE, 2014) |
| "Extraparenchymal neurocysticercosis is the most severe form of cysticercosis, and response to treatment is suboptimal." | 1.51 | Factors Associated With Cysticidal Treatment Response in Extraparenchymal Neurocysticercosis. ( Carrillo-Mezo, R; Fleury, A; González-Hernández, I; Jung, H; Matus, C; Osorio, R; Romo, ML; Toledo, A, 2019) |
| "Neurocysticercosis is the most common parasitic infection of the central nervous system." | 1.33 | Resolution of arterial stenosis in a patient with periarterial neurocysticercosis treated with oral prednisone. ( Bouldin, A; Pinter, JD, 2006) |
| "Cysticercosis is an helminthic disease which is usually observed in endemic areas or in immigrants coming from these areas." | 1.32 | [Neurocysticercosis complicating the treatment of cutaneous cysticercosis in a traveller]. ( Bricaire, E; Caumes, E; Chemali, N; Danis, M; Epelboin, L; Klement, E, 2004) |
| "A CT scan showed severe hydrocephalus and calcifications, prompting a ventriculoperitoneal shunt placement." | 1.30 | Transient hemifacial spasm associated with subarachnoid brainstem cysticercosis: a case report. ( Ramos-Peek, J; Revuelta Gutierrez, R; Soto-Hernández, JL; Suastegui-Roman, R, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez-Jacoiste Asín, MA | 1 |
| Calleja-Castaño, P | 1 |
| Hilario, A | 1 |
| Thapa, K | 1 |
| Romo, ML | 3 |
| Carpio, A | 3 |
| Leslie, D | 3 |
| Andrews, H | 3 |
| Hauser, WA | 3 |
| Kelvin, EA | 3 |
| Osorio, R | 1 |
| Carrillo-Mezo, R | 1 |
| Toledo, A | 1 |
| Matus, C | 1 |
| González-Hernández, I | 1 |
| Jung, H | 1 |
| Fleury, A | 1 |
| Min, Z | 1 |
| Naddaf, E | 1 |
| Seeger, SK | 1 |
| Stafstrom, CE | 1 |
| Ramos-Zúñiga, R | 1 |
| Pérez-Gómez, HR | 1 |
| Gaytán-Martínez, LA | 1 |
| Vega-Ruiz, B | 1 |
| Soto-Rodríguez, S | 1 |
| Rochín-Mozqueda, A | 1 |
| Wyka, K | 1 |
| Bagiella, E | 2 |
| Marquez-Romero, JM | 1 |
| Santana-López, JM | 1 |
| Espinoza-López, DA | 1 |
| Zermeño, F | 1 |
| Castillo-Iglesias, H | 1 |
| Mouly, S | 1 |
| Ducros, A | 1 |
| Sarfati, C | 1 |
| Sulahian, A | 1 |
| Bergmann, JF | 1 |
| Bouldin, A | 1 |
| Pinter, JD | 1 |
| Epelboin, L | 1 |
| Klement, E | 1 |
| Chemali, N | 1 |
| Danis, M | 1 |
| Bricaire, E | 1 |
| Caumes, E | 1 |
| Leon, P | 1 |
| Revuelta Gutierrez, R | 1 |
| Soto-Hernández, JL | 1 |
| Suastegui-Roman, R | 1 |
| Ramos-Peek, J | 1 |
| Belo, M | 1 |
| Grunitzky, EK | 1 |
| Balogou, A | 1 |
| Kowu, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study of Neurocysticercosis Treatment[NCT00283699] | Phase 3 | 178 participants (Actual) | Interventional | 2001-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for prednisone and Neurocysticercosis
| Article | Year |
|---|---|
Neurocysticercosis in Wisconsin: 3 cases and a review of the literature.
Topics: Adult; Albendazole; Anthelmintics; Diagnosis, Differential; Diagnostic Imaging; Drug Therapy, Combin | 2014 |
3 trials available for prednisone and Neurocysticercosis
| Article | Year |
|---|---|
The effect of albendazole treatment on non-seizure outcomes in patients with symptomatic neurocysticercosis.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Double-Blind Method; Drug Administration | 2018 |
The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis.
Topics: Albendazole; Animals; Anthelmintics; Anti-Inflammatory Agents; Brain; Cysts; Drug Therapy, Combinati | 2015 |
Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Albendazole; Anti-Inflammatory Agents; Antiparasitic Agents; Brain; | 2008 |
10 other studies available for prednisone and Neurocysticercosis
| Article | Year |
|---|---|
Lumbosacral Radiculopathy as the Clinical Presentation of Neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Anti-Inflammatory Agents; Antibodies, Helminth; Female; Humans; I | 2020 |
Factors Associated With Cysticidal Treatment Response in Extraparenchymal Neurocysticercosis.
Topics: Adult; Age Factors; Albendazole; Anthelmintics; Dexamethasone; Drug Therapy, Combination; Female; Hu | 2019 |
Parenchymal neurocysticercosis.
Topics: Adult; Albendazole; Animals; Humans; Male; Mexican Americans; Neurocysticercosis; Prednisone; Taenia | 2015 |
[Temporal lobe epilepsy and active neurocysticercosis: two representative case reports].
Topics: Albendazole; Anomia; Anthelmintics; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Citalopram | 2015 |
Conservative treatment of a ruptured inflammatory infectious aneurysm caused by neurocysticercosis.
Topics: Adult; Aneurysm, Infected; Aneurysm, Ruptured; Anti-Inflammatory Agents; Brain; Headache; Humans; In | 2012 |
Late-onset eosinophilic chronic meningitis occurring 30 years after Taenia solium infestation in a white Caucasian woman.
Topics: Albendazole; Animals; Anthelmintics; Chronic Disease; Eosinophilia; Female; Glucocorticoids; Headach | 2006 |
Resolution of arterial stenosis in a patient with periarterial neurocysticercosis treated with oral prednisone.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Chorea; Gadoliniu | 2006 |
[Neurocysticercosis complicating the treatment of cutaneous cysticercosis in a traveller].
Topics: Adult; Albendazole; Anthelmintics; Brain Edema; Combined Modality Therapy; Confusion; Cysticercosis; | 2004 |
Transient hemifacial spasm associated with subarachnoid brainstem cysticercosis: a case report.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Brain Stem; Calcinosis; Evoked Potentials, Auditory, | 1998 |
[Cerebral cysticercosis and headache in a young Togolese woman].
Topics: Adult; Anthelmintics; Brain Diseases; Female; France; Headache; Humans; Neurocysticercosis; Praziqua | 2001 |